| |
|
By Ed Susman, writer for docguide.com
SALT
LAKE CITY, UT -- October 25, 2006 -- Treatment with the investigative
oral agent ambrisentan appear to be helpful for patients with
pulmonary arterial hypertension (PAH), researchers reported
here at CHEST 2006, the annual meeting of the American College
of Chest Physicians. |
 |
|
 |
| Dr.
Frank Arnett is interviewed Oct. 3 by KTRK-TV reporter
Christi Myers during the funding announcement for the
new Center for Clinical and Translational Sciences.
(Photo by Ester Fant) |
The
University of Texas Health Science Center at Houston has been
awarded a five-year, $7.5 million grant to help medical researchers
and physicians turn research discoveries into new drugs, treatments
and diagnostics for people living with scleroderma. |
|
|
Actelion
Pharmaceuticals US, Inc. is pleased to announce the launch
of Sure Steps™, a comprehensive support program for
patients enrolled in the Tracleer Access Program (T.A.P.).
The program is available only in the U.S. |
|
|
The
Scleroderma Foundation is now selling navy blue windbreakers
for $35 plus $5 shipping. |
|
Watch
Kenny Wallace Race This Saturday
Scleroderma awareness comes to Arizona Sat., Nov. 11. Please
be sure to watch for the Scleroderma Foundation’s logo
on the #22 car of our awareness partner—Kenny Wallace—as
he races in the Arizona Travel 200 at Phoenix International
Raceway in Avondale, Arizona.
This race will air on NBC television and PRN radio networks.
The race will air at 3:30 p.m. eastern. Support Kenny and
help spread scleroderma awareness.
Last week Kenny finished 16th. |
|
|
 In
addition to our nationwide network of Chapters
and Support
Groups, we offer you electronic ways to connect with other
people.
|
Upcoming
Events |
| |
